Lotus Pharmaceutical Co Ltd
TWSE:1795

Watchlist Manager
Lotus Pharmaceutical Co Ltd Logo
Lotus Pharmaceutical Co Ltd
TWSE:1795
Watchlist
Price: 281.5 TWD -1.4% Market Closed
Market Cap: 74.7B TWD
Have any thoughts about
Lotus Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Lotus Pharmaceutical Co Ltd stock under the Base Case scenario is 271.03 TWD. Compared to the current market price of 281.5 TWD, Lotus Pharmaceutical Co Ltd is Overvalued by 4%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
271.03 TWD
Overvaluation 4%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
31
vs Industry
28
Median 3Y
4.1
Median 5Y
3
Industry
2.5
Forward
3.9
vs History
80
vs Industry
25
Median 3Y
18.7
Median 5Y
19.8
Industry
21.9
Forward
14.3
vs History
79
vs Industry
20
Median 3Y
22.6
Median 5Y
20.9
Industry
16.5
vs History
12
vs Industry
13
Median 3Y
30.4
Median 5Y
23.4
Industry
23.6
vs History
33
vs Industry
17
Median 3Y
4.2
Median 5Y
3.2
Industry
2.1
vs History
33
vs Industry
25
Median 3Y
4.7
Median 5Y
3.4
Industry
2.6
Forward
4.3
vs History
33
vs Industry
22
Median 3Y
8.3
Median 5Y
6.9
Industry
5.2
vs History
39
vs Industry
25
Median 3Y
13.1
Median 5Y
12.6
Industry
13.3
Forward
10.4
vs History
53
vs Industry
23
Median 3Y
16.8
Median 5Y
16.9
Industry
16.6
Forward
13.5
vs History
82
vs Industry
19
Median 3Y
24.7
Median 5Y
23.3
Industry
15.6
vs History
25
vs Industry
9
Median 3Y
-20.7
Median 5Y
-28.2
Industry
19.1
vs History
33
vs Industry
29
Median 3Y
2.5
Median 5Y
1.9
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Lotus Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
TW
Lotus Pharmaceutical Co Ltd
TWSE:1795
74.4B TWD 4.4 18.5 14.2 18.1
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
TW
Lotus Pharmaceutical Co Ltd
TWSE:1795
Average P/E: 30.7
18.5
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top